What is meant by self coagulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Self-Coagulation in Medical Context

Self-coagulation refers to patient self-management of oral anticoagulation therapy, where patients independently test their INR (International Normalized Ratio) using portable coagulometers and adjust their warfarin dosing accordingly 1.

What Self-Coagulation Involves

Self-coagulation (more accurately termed "self-management of anticoagulation") is a structured program where patients:

  • Perform their own INR testing using portable coagulometers at home
  • Interpret the INR results based on individualized treatment strategies
  • Adjust warfarin doses according to predetermined algorithms without requiring clinic visits for each test

Key Requirements for Self-Coagulation Programs

Patient Selection Criteria

  • Only patients requiring long-term warfarin therapy should be considered 1
  • Patients must be willing and able to perform self-management 1
  • Previous compliance with clinic attendance and medication is essential—non-compliance, including alcohol misuse, is a contraindication 1

Training and Competency

  • Patients must demonstrate competence in INR testing assessed by trained healthcare professionals before home testing 1
  • Patients must show competence in correctly interpreting INR results and adjusting doses based on individualized strategies 1
  • Training typically takes 2-3 months before patients become fully accustomed to managing their treatment 1

Quality Control Requirements

  • Electronic quality control should be performed every time the coagulometer is used 1
  • External quality control must be performed regularly (e.g., every 6 months) by comparing home device results with clinic coagulometers—results within 0.5 of each other are considered satisfactory 1
  • Internal quality control must be performed at least monthly or every time the device is used if testing is less frequent 1

Clinical Oversight

  • Patients must remain under the care of a named clinician (typically a consultant haematologist) who maintains clinical responsibility 1
  • Six-month reviews with the responsible clinician are mandatory 1
  • The patient's GP and the clinician who initiated warfarin must be informed 1

Important Caveats

Previous INR stability is NOT required for self-management—unstable patients may actually benefit from increased autonomy and more frequent testing 1. Only portable coagulometers that have undergone acceptable evaluation by expert bodies (e.g., UK Medical Devices Agency) should be used 1.

If external quality control is unsatisfactory on multiple occasions, the patient's technique and device must be reassessed, and persistently poor performance requires withdrawal from the program 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.